Drug development company Acelyrin Inc. recently saw a modest increase in its stock price after announcing the adoption of a ...

We recently published a list of 10 Best Short-Term Stocks To Buy Right Now. In this article, we are going to take a look at ...

Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to ...

Alumis Inc., a clinical-stage biopharmaceutical company, announced key developments in its pipeline and a merger with ACELYRIN during its recent financial results release. At the AAD 2025 ...

In this article, we are going to take a look at where Acelyrin, Inc. (NASDAQ:SLRN) stands against other best short-term stocks with a buying opportunity for investors. Thrilling highs, daunting ...

Babler added “The announcement of the merger agreement with ACELYRIN represents a significant step forward in Alumis' strategic progress that will create a leading immunology and inflammation ...

SOUTH SAN FRANCISCO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to ...

This article summarizes the most significant insider buying and selling activities reported for US stocks on Monday, March 17, 2025. Top Insider Buys: Forum Energy Technologies , ...